Research Outputs

Now showing 1 - 3 of 3
  • Thumbnail Image
    Publication
    Identification of novel coumarin based compounds as potential inhibitors of the 3-Chymotrypsin-like main protease of Sars-Cov-2 Using Dft, molecular docking and molecular dynamics simulation studies
    (Journal of the Chilean Chemical Society, 2022)
    Cardona, Wilson
    ;
    Mendoza Huizar, L.H.
    ;
    ;
    Salgado Moran, G.
    ;
    Abdizadeh, Tooba
    SARS-CoV-2 is the pandemic disease-causing agent COVID-19 with high infection rates. Despite the progress made in vaccine development, there is an urgent need for the identification of antiviral compounds that can tackle better the different phases of SARS-CoV-2. The main protease (Mpro or 3CLpro) of SARS-CoV-2 has a crucial role in viral replication and transcription. In this study, an in silico method was executed to elucidate the inhibitory potential of the synthesized 6-tert-octyl and 6-8-ditert-butyl coumarin compounds against the major protease of SARS-CoV-2 by comprehensive molecular docking and density functional theory (DFT), ADMET properties and molecular dynamics simulation approaches. Both compounds shown favorable interactions with the 3CLpro of the virus. From DFT calculations, HOMO-LUMO values and global descriptors indicated promising results for these compounds. Furthermore, molecular dynamics studies revealed that these ligand-receptor complexes remain stable during simulations and both compounds showed considerably high binding affinity to the main SARS-CoV-2 protease. The results of the study suggest that the coumarin compounds 6-tert-octyl and 6-8-ditert-butyl could be considered as promising scaffolds for the development of potential COVID-19 inhibitors after further studies.
  • Thumbnail Image
    Publication
    Minor composition compounds of algerian herbal medicines as inhibitors of sars-cov-2 main protease: Molecular docking and admet properties prediction
    (Journal of the Chilean Chemical Society, 2021) ;
    Yabrir, B.
    ;
    Belhassan, A.
    ;
    Lakhlifi, T.
    ;
    Salgado, G.
    ;
    Bouachrine, M.
    ;
    Munoz, P.
    ;
    Ramirez, R.
    The identification of drugs against the new coronavirus (SARS-CoV-2) is an important requirement. Natural products are substances that serve as sources of beneficial chemical molecules for the development of effective therapies. In this study, 187 natural compounds from Algerian herbal medicines were docked in the active site of SARS-CoV-2 main protease. The result indicates that Piperitol, Warfarin, cis-calamenen-10-ol and α-Cadinene are the structures with best affinity in the binding site of the studied enzyme and all of them respect the conditions mentioned in Lipinski’s rule and have acceptable ADMET proprieties; so, these compounds could have more potent antiviral treatment of COVID-19 than the studied compounds, and they have important pharmacokinetic properties and bioavailability.
  • Thumbnail Image
    Publication
    A computational predicting of possible inhibitors of the main SARS-CoV-2 protease found in Algerian herbal medicines
    (Universidad Nacional de Colombia, 2022) ;
    Yabrir, Benalia
    ;
    Belhassan, Assia
    ;
    Salgado-Moran, Guillermo
    ;
    Lakhlifi, Tahar
    ;
    Bouachrine, Mohammed
    COVID-19 is a zoonotic viral disease caused by the SARS-CoV-2 virus. Its abrupt outbreak has caused a tremendous challenge to public health systems due to the rapid spread of the virus. In this sense, a great deal of work has been focused on finding substances from herbal plants to be used against this virus. In order to investigate the molecular interactions between natural metabolites from Algerian herbal plants and the SARS-CoV-2 protease Mpro, computational docking and molecular dynamics were used, also the drug likeness degree and in silico ADMET prediction were carried out in this study. warfarin and catalponol preferentially binds to a pocket of the SARS-Cov-2 Mpro active site that is made up of residues His 41 to Glu 166 and Leu 27 to His 163 with a relatively low binding energy of -7.1 and -6.6 kcal/mol respectively. Dynamic molecular assay further established that only warfarin managed to stay in the active site. The results suggest that warfarin may be an interesting candidate for development as a medical treatment of COVID-19 and more research is proposed, without disregarding its toxicity which deserves to be well studied.